期刊文献+

C3 F8或硅油填充对增生型糖尿病视网膜病变玻璃体切割手术后玻璃体再积血及视力预后的影响 被引量:2

Effects of C3 F8 or silicon oil tamponade on postoperative vitreous hemorrhage and visual prognosis after vitrectomy for proliferative diabetic retinopathy
原文传递
导出
摘要 目的:观察 C3 F8或硅油填充对增生型糖尿病视网膜病变(PDR)玻璃体切割手术后玻璃体再积血及视力预后的影响。方法首次行玻璃体切割手术联合 C3 F8或硅油填充的 PDR 患者121例127只眼纳入研究。根据玻璃体腔填充物不同将患眼分为 C3 F8填充组、硅油填充组,分别为53例56只眼和68例71只眼。两组患者性别(χ2=0.956)、年龄(t =1.122)、糖尿病病程(t =0.627)、空腹血糖(t =1.049)、收缩压(t=1.056)、舒张压(t=0.517)、高血压病史(χ2=0.356)、肾病史(χ2=1.242)、手术前行视网膜激光光凝(χ2=1.225)及同期晶状体摘除(χ2=1.299)眼数比较,差异均无统计学意义(P 〉0.05);糖尿病视网膜病变分期(Z =2.479)、最佳矫正视力(BCVA)(Z =2.066)比较,差异均有统计学意义(P 〈0.05)。所有患眼行常规睫状体平坦部三切口玻璃体切割手术。手术后随访6个月~4.0年,平均随访时间2.0年。观察并比较两组患眼手术后玻璃体再积血的发生率、时间及 BCVA 变化情况。结果C3 F8填充组56只眼中,发生玻璃体再积血14只眼,占25.00%。发生玻璃体再积血时间为手术后7~225 d,平均时间为(64.64±59.09)d,且30~60 d 发生比例最高,占35.71%。硅油填充组71只眼中,硅油取出手术后发生玻璃体再积血7只眼,占9.89%。发生玻璃体再积血时间为3~65 d,平均时间为(25.29±20.46)d,且15~30 d 发生比例最高,占42.86%。与 C3 F8填充组比较,硅油填充组手术后玻璃体再积血率显著降低,差异有统计学意义(χ2=5.200,P 〈0.05)。两组患眼手术后 BCVA 均较手术前提高,差异有统计学意义(Z =2.472、3.114,P 〈0.05)。两组间比较,硅油填充组手术后 BCVA 低于 C3 F8填充组,差异有统计学意义(Z =1.968,P 〈0.05)。结论C3 F8与硅油填充均可改善 PDR 患者玻璃体切割手术后视力。与 C3 F8相比,硅油填充可显著降低并延迟手术后玻璃体再积血。 Objective To compare the effects of intravitreal tamponade of C3 F8 with silicon oil on postoperative vitreous hemorrhage and visual prognosis after vitrectomy for proliferative diabetic retinopathy (PDR).Methods The clinical data of 121 patients (127 eyes)who underwent primary vitrectomy due to PDR were analyzed retrospectively.All the patients were divided into two groups according to different intravitreal tamponade, including C3 F8 tamponade group (53 patients with 56 eyes ) and silicone oil tamponade group (68 patients with 71 eyes).There was no difference of gender (χ2 = 0.956 ),age (t =1.122),duratiion of diabetes (t=0.627),fasting blood glucose (t=1.049),systolic pressure (t=1.056), diastolic pressure (t = 0.5 1 7 ), history of hypertension (χ2 = 0.356 ), nephropathy (χ2 = 1.242 ), preoperative laser photocoagulation (χ2 = 1.225 )and All the patients underwent three port pars plana vitrectomy.The mean follow-up was 2 years ranging from 6 months to 4 years.And then the incidence and onset time of postoperative vitreous hemorrhage and postoperative BCVA of the two groups were compared. Results Postoperative vitreous hemorrhage occurred in 14 of 56 eyes (25.00%)in C3 F8 tamponade group. The average onset time of postoperative vitreous hemorrhage were (64.64 ± 59.09)days ranging from 7 -225 days and mostly were within 30-60 days (35.71%,5/14).Postoperative vitreous hemorrhage also occurred in 7 of 71 eyes (9.89%)of silicone oil tamponade group after silicone oil removal with an average onset time of (25.29±20.46)days ranging from 3-65 days and were mostly within 1 5-30 days (42.86%, 3/7).There was a significant difference in the incidence of postoperative vitreous hemorrhage between the two groups (χ2 = 5.200,P 〈0.05 ).BCVA of the two groups was improved significantly after operation (Z =2.472,3.1 14;P〈0.05).Postoperative BCVA of silicone oil tamponade group was poorer than C3 F8 tamponade group (Z =1.968,P 〈0.05).Conclusion Both C3 F8 and silicone oil tamponade can improve the visual acuity after vitrectomy for PDR.Compared with C3 F8 ,silicone oil tamponade had lower incidence and late onset of postoperative vitreous hemorrhage after vitrectomy for PDR.
作者 范玲玲 颜华
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2015年第4期333-336,共4页 Chinese Journal of Ocular Fundus Diseases
关键词 糖尿病视网膜病变/外科学 惰性气体/治疗应用 硅油类/治疗应用 玻璃体出血 玻璃体视网膜手术 Diabetic retinopathy/surgery Noble gases/therapeutic use Silicone oils/therapeutic use Vitreous hemorrhage Vitreoretinal surgery
  • 相关文献

参考文献12

  • 1Newman DK. Surgical management of the late complications of proliferative diabetic retinopathy [J]. Eye (Lond), 2010,24(3) : 414-419.
  • 2Gupta V, Arevalo JF. Surgical management of diabetic retinopathy [J]. Middle East Afr J Ophthalmol, 2013, 20 (4) : 283-292.
  • 3Yang CM,Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy [J]. Ophthalmology, 2007,114(4) : 710-715.
  • 4Castellarin A, Grigorian R, Bhagat N, et al. Vitrectomy with silicone oil infusion in severe diabetic retinopathy [J]. Br J Ophthalmol, 2003, 87(3)318-321.
  • 5王雨晴,宋晏平,张招德,林文雅,唐涵锋.玻璃体切除术后并发症临床分析[J].国际眼科杂志,2014,14(1):112-115. 被引量:15
  • 6Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellltus and its complications. Part 1 diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]. Diabet Med, 1998, 15 (7) :539-553.
  • 7中华医学会眼科学分会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42.
  • 8Yan H, Cui J, Lu Y, et al. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy [J]. Curr Eye Res, 2010, 35(4):308-313.
  • 9Khuthaila MK, Hsu J, Chiang A, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitreetomy [J]. Am J Ophthalmol, 2013,155(4) :757-763.
  • 10Gupta B, Wong R, Sivaprasad S, et al. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice [J]. Eye (Lond), 2012, 26(4) :576-582.

二级参考文献18

共引文献25

同被引文献683

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部